FDA Panel Recommends Pfizer’s Osteoporosis Drug For Postmenopausal Women - Tidingo.com

FDA Panel Recommends Pfizer’s Osteoporosis Drug For Postmenopausal Women

Link:

Fablyn, an experimental drug manufactured by Pfizer Inc. for treatment of osteoporosis, has been determined by the FDA to have health benefits that outweigh its risks. The FDA panel met in Rockville, Maryland and voted 9-3 to recommend the drug for postmenopausal women with osteoporosis.

read more

FDA Panel Recommends Pfizer’s Osteoporosis Drug For Postmenopausal Women - témata

Panel, Recommends, Pfizer’s, Osteoporosis, Drug, For, Postmenopausal, Women, FDA Panel Recommends Pfizer’s Osteoporosis Drug For Postmenopausal Women , Pfizer, Inc, FDA, The, Rockville, Maryland, 9-3, Fablyn,, Pfizer Inc., The FDA, Rockville, Maryland, FDA Panel Recommends Pfizer’s Osteoporosis Drug For Postmenopausal Women,

Podobné zprávy

RSS sources

Your own sources

Your own RSS you can add after registration

Public sources


Create an account Password
© 2005-2008  
RSS Sources list
Loading messages